SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (10242)6/29/1998 6:16:00 PM
From: John W. Andrews  Respond to of 23519
 
the loss will be 40-50cents a share according to a realiable source......anything better that this will be a welcome suprise....

All in all if scripts do head north and more and more countries are available for international sales this quarters earnings really mean nothing.....everybody expects a bad quarter...

Pizzaman



To: VLAD who wrote (10242)6/29/1998 6:17:00 PM
From: DaiS  Read Replies (1) | Respond to of 23519
 
Vlad,

I agree about the lag. But when muse was first introduced, recruitment from the huge number of new users could have been as low as 10%. So if the repeats bleed - as suggested by this weeks data - we need a lot of new scripts in hurry to halt decline in repeats in mid term. I am prepared to wait long term, but it looks bad and mangement must do something.

DaiS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News